Basic Search
|
Summaries
|
Advanced SearchViolation Tracker Individual Record
Company: Indivior, Inc.
Current Parent Company:
Indivior PLC
Parent at the Time of the Penalty Announcement:
subscribe to see this data field
Penalty: $10,000,000
Year: 2020
Date: July 24, 2020
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Secondary Offense: consumer protection violation
Violation Description: Indivior, Inc. agreed to pay $10 million to settle Federal Trade Commission allegations that it violated antitrust laws through a deceptive scheme to thwart lower priced generic competition with its branded opioid replacement therapy drug Suboxone.
Level of Government: federal
Action Type: agency action
Agency: Federal Trade Commission
Civil or Criminal Case: civil
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: specialty pharmaceuticals
Source of Data:
(click here)
Archived Source:
(click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the
Update Log.
